Bennett Associates Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$613K Buy
666
+224
+51% +$227K 0.41% 27
2025
Q4
$475K Buy
442
+133
+43% +$127K 0.33% 32
2025
Q3
$236K Buy
+309
New +$230K 0.17% 45

Other funds holding LLY

Bennett Associates Wealth Management's LLY Position: Q1 2026 in Review

Bennett Associates Wealth Management increased its Eli Lilly (LLY) stake by 51% in Q1 2026, buying an estimated $227K and bringing the position to 666 shares worth $613K. The position accounts for 0.41% of the portfolio, ranked #27.

Bennett Associates Wealth Management first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bennett Associates Wealth Management held 666 shares of Eli Lilly worth $613K as of Q1 2026.
  • Bennett Associates Wealth Management bought 224 Eli Lilly shares in Q1 2026, an estimated $227K.
  • Eli Lilly made up 0.41% of Bennett Associates Wealth Management's portfolio in Q1 2026, its #27 holding.
  • Bennett Associates Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bennett Associates Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.